APA引文

Taylor, P., Christensen, R., Moosavi, S., Selema, P., Guilatco, R., Fowler, H., . . . Haraoui, B. (2019). Real-world safety data from patients with rheumatic diseases treated with CT-P13, an infliximab biosimilar: An interim analysis from an observational study. BMJ Journals.

Chicago Style (17th ed.) Citation

Taylor, P., R. Christensen, S. Moosavi, P. Selema, R. Guilatco, H. Fowler, C. Bombardier, and B. Haraoui. Real-world Safety Data from Patients with Rheumatic Diseases Treated with CT-P13, an Infliximab Biosimilar: An Interim Analysis from an Observational Study. BMJ Journals, 2019.

MLA引文

Taylor, P., et al. Real-world Safety Data from Patients with Rheumatic Diseases Treated with CT-P13, an Infliximab Biosimilar: An Interim Analysis from an Observational Study. BMJ Journals, 2019.